Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Peru

Global PrEP Tracker
Last Updated: 22 October 2024

Drug Registration Status

Approved
Not
Approved
Under
Review
Data not
available
Gilead's Truvada (TDF/xTC*) Registration
Approved 2021 2021
Generic versions of TDF/xTC* for prevention
Not Approved
ViiV's Apretude (CAB for PrEP) Registration
Approved 2023 2023
IPM's Dapivirine Vaginal Ring Registration
Not Approved
Oral F/TAF (Descovy) Registration
Not Approved
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

N/A Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

2 Planned/Ongoing Projects

Est. Cumulative
Initiations:

Total PrEP: 3,088

Oral PrEP: 3,088

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Featured Resources

External Link

Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study

This article from the Journal of the International AIDS Society assesses factors associated with long-term PrEP engagement and adherence among trans women enrolled in the Implementation of PrEP (ImPrEP) study, the largest PrEP demonstration study in Latin America.
View All Resources